• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

藻类代谢产物作为抗耐甲氧西林金黄色葡萄球菌（MRSA）的新型疗法：综述

Algal Metabolites as Novel Therapeutics Against Methicillin-Resistant (MRSA): A Review.

作者信息

Ibraheem Ibraheem Borie M, Alharbi Reem Mohammed, Abdel-Raouf Neveen, Al-Enazi Nouf Mohammad, Alsamhary Khawla Ibrahim, Ali Hager Mohammed

机构信息

Botany and Microbiology Department, Faculty of Science, Beni-Suef University, Beni-Suef 62521, Egypt.

Biology Department, Science College, University of Hafr Al-Batin, Hafr Al-Batin 39524, Saudi Arabia.

出版信息

Pharmaceutics. 2025 Jul 30;17(8):989. doi: 10.3390/pharmaceutics17080989.

DOI:10.3390/pharmaceutics17080989
PMID:40871012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12389059/
Abstract

Methicillin-resistant (MRSA), a multidrug-resistant pathogen, poses a significant threat to global healthcare. This review evaluates the potential of marine algal metabolites as novel antibacterial agents against MRSA. We explore the clinical importance of , the emergence of MRSA as a "superbug", and its resistance mechanisms, including target modification, drug inactivation, efflux pumps, biofilm formation, and quorum sensing. The limitations of conventional antibiotics (e.g., β-lactams, vancomycin, macrolides) are discussed, alongside the promise of algal-derived compounds such as fatty acids, pigments, polysaccharides, terpenoids, and phenolic compounds. These metabolites exhibit potent anti-MRSA activity by disrupting cell division (via FtsZ inhibition), destabilizing membranes, and inhibiting protein synthesis and metabolic pathways, effectively countering multiple resistance mechanisms. Leveraging advances in algal biotechnology, this review highlights the untapped potential of marine algae to drive innovative, sustainable therapeutic strategies against antibiotic resistance.

摘要

耐甲氧西林金黄色葡萄球菌（MRSA）是一种多重耐药病原体，对全球医疗保健构成重大威胁。本综述评估了海洋藻类代谢产物作为抗MRSA新型抗菌剂的潜力。我们探讨了MRSA作为“超级细菌”出现的临床重要性及其耐药机制，包括靶点修饰、药物失活、外排泵、生物膜形成和群体感应。讨论了传统抗生素（如β-内酰胺类、万古霉素、大环内酯类）的局限性，以及藻类衍生化合物（如脂肪酸、色素、多糖、萜类化合物和酚类化合物）的前景。这些代谢产物通过破坏细胞分裂（通过抑制FtsZ）、破坏细胞膜稳定性以及抑制蛋白质合成和代谢途径，展现出强大的抗MRSA活性，有效对抗多种耐药机制。利用藻类生物技术的进展，本综述强调了海洋藻类在推动针对抗生素耐药性的创新、可持续治疗策略方面尚未开发的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a7/12389059/7c8ded98364d/pharmaceutics-17-00989-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a7/12389059/e565b7890d01/pharmaceutics-17-00989-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a7/12389059/87cd80b93654/pharmaceutics-17-00989-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a7/12389059/cb82408b05e1/pharmaceutics-17-00989-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a7/12389059/5dbdbe05c975/pharmaceutics-17-00989-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a7/12389059/0bfbeaa5cd36/pharmaceutics-17-00989-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a7/12389059/c41c8270d987/pharmaceutics-17-00989-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a7/12389059/105525941795/pharmaceutics-17-00989-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a7/12389059/c3c381ec5550/pharmaceutics-17-00989-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a7/12389059/0073bd7909af/pharmaceutics-17-00989-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a7/12389059/42bf40b5b61d/pharmaceutics-17-00989-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a7/12389059/7c8ded98364d/pharmaceutics-17-00989-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a7/12389059/e565b7890d01/pharmaceutics-17-00989-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a7/12389059/87cd80b93654/pharmaceutics-17-00989-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a7/12389059/cb82408b05e1/pharmaceutics-17-00989-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a7/12389059/5dbdbe05c975/pharmaceutics-17-00989-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a7/12389059/0bfbeaa5cd36/pharmaceutics-17-00989-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a7/12389059/c41c8270d987/pharmaceutics-17-00989-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a7/12389059/105525941795/pharmaceutics-17-00989-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a7/12389059/c3c381ec5550/pharmaceutics-17-00989-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a7/12389059/0073bd7909af/pharmaceutics-17-00989-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a7/12389059/42bf40b5b61d/pharmaceutics-17-00989-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a7/12389059/7c8ded98364d/pharmaceutics-17-00989-g011.jpg

相似文献

1
Algal Metabolites as Novel Therapeutics Against Methicillin-Resistant (MRSA): A Review.藻类代谢产物作为抗耐甲氧西林金黄色葡萄球菌（MRSA）的新型疗法：综述
Pharmaceutics. 2025 Jul 30;17(8):989. doi: 10.3390/pharmaceutics17080989.
2
Bacteriophage infection drives loss of β-lactam resistance in methicillin-resistant .噬菌体感染导致耐甲氧西林菌丧失β-内酰胺抗性 。
Elife. 2025 Jul 10;13:RP102743. doi: 10.7554/eLife.102743.
3
Deciphering the dynamics of methicillin-resistant Staphylococcus aureus biofilm formation: from molecular signaling to nanotherapeutic advances.解析耐甲氧西林金黄色葡萄球菌生物膜形成的动态过程：从分子信号到纳米治疗进展。
Cell Commun Signal. 2024 Mar 22;22(1):188. doi: 10.1186/s12964-024-01511-2.
4
Role of methicillin-resistant Staphylococcus aureus in cutaneous infections: Current treatments and therapeutic approaches for future advancement.耐甲氧西林金黄色葡萄球菌在皮肤感染中的作用：当前治疗方法及未来进展的治疗途径
Int J Pharm. 2025 Aug 14;684:126030. doi: 10.1016/j.ijpharm.2025.126030.
5
Harnessing diversity and antagonism within the pig skin microbiota to identify novel mediators of colonization resistance to methicillin-resistant .利用猪皮肤微生物群中的多样性和拮抗作用来鉴定耐甲氧西林金黄色葡萄球菌定植抗性的新型介质。
mSphere. 2023 Aug 24;8(4):e0017723. doi: 10.1128/msphere.00177-23. Epub 2023 Jul 5.
6
Adaptive laboratory-evolved MRSA with PPEF manifests cross-susceptibility to oxacillin and hypersensitivity to ciprofloxacin.具有PPEF的适应性实验室进化型耐甲氧西林金黄色葡萄球菌对苯唑西林表现出交叉敏感性，对环丙沙星表现出超敏反应。
Microbiol Spectr. 2025 Aug 5;13(8):e0297424. doi: 10.1128/spectrum.02974-24. Epub 2025 Jul 15.
7
Anti-bacterial activity of dermcidin in human platelets: suppression of methicillin-resistant growth.人血小板中防御素的抗菌活性：抑制耐甲氧西林菌生长。
Microbiol Spectr. 2025 Jul;13(7):e0327324. doi: 10.1128/spectrum.03273-24. Epub 2025 May 27.
8
Antibacterial and antibiofilm potentials of vancomycin-loaded niosomal drug delivery system against methicillin-resistant Staphylococcus aureus (MRSA) infections.载万古霉素的脂质体药物传递系统对耐甲氧西林金黄色葡萄球菌（MRSA）感染的抗菌和抗生物膜潜力。
BMC Biotechnol. 2024 Jul 8;24(1):47. doi: 10.1186/s12896-024-00874-1.
9
Targeting the MEK1/2 pathway to combat infection and inflammation in cystic fibrosis.靶向MEK1/2信号通路以对抗囊性纤维化中的感染和炎症。
mBio. 2025 Jul 9;16(7):e0077525. doi: 10.1128/mbio.00775-25. Epub 2025 May 27.
10
Mapping of quorum sensing interaction network of commensal and pathogenic staphylococci.共生和致病性葡萄球菌群体感应相互作用网络的映射
mBio. 2025 Jul 16:e0096725. doi: 10.1128/mbio.00967-25.

本文引用的文献

1
Using Constellation Pharmacology to Characterize a Novel α-Conotoxin from .利用星座药理学研究一种新型α-芋螺毒素。
Mar Drugs. 2024 Feb 29;22(3):118. doi: 10.3390/md22030118.
2
Vaccines to Treat Substance Use Disorders: Current Status and Future Directions.用于治疗物质使用障碍的疫苗：现状与未来方向
Pharmaceutics. 2024 Jan 8;16(1):84. doi: 10.3390/pharmaceutics16010084.
3
Metal nanoparticles as inhibitors of enzymes and toxins of multidrug-resistant .金属纳米颗粒作为多重耐药性酶和毒素的抑制剂
Infect Med (Beijing). 2023 Nov 21;2(4):294-307. doi: 10.1016/j.imj.2023.11.006. eCollection 2023 Dec.
4
Supercapatteries as Hybrid Electrochemical Energy Storage Devices: Current Status and Future Prospects.超级电容器作为混合电化学储能装置：现状与未来展望
Molecules. 2024 Jan 2;29(1):243. doi: 10.3390/molecules29010243.
5
Myco-Synthesized Selenium Nanoparticles as Wound Healing and Antibacterial Agent: An In Vitro and In Vivo Investigation.真菌合成的硒纳米颗粒作为伤口愈合和抗菌剂：一项体外和体内研究
Microorganisms. 2023 Sep 19;11(9):2341. doi: 10.3390/microorganisms11092341.
6
Antimicrobial Peptides from Photosynthetic Marine Organisms with Potential Application in Aquaculture.来自光合海洋生物的抗菌肽及其在水产养殖中的潜在应用。
Mar Drugs. 2023 May 8;21(5):290. doi: 10.3390/md21050290.
7
Revisiting the role of cyanobacteria-derived metabolites as antimicrobial agent: A 21st century perspective.重新审视蓝藻衍生代谢产物作为抗菌剂的作用：21世纪的视角。
Front Microbiol. 2022 Nov 18;13:1034471. doi: 10.3389/fmicb.2022.1034471. eCollection 2022.
8
Antimicrobial therapeutics isolated from algal source: retrospect and prospect.从藻类来源分离的抗菌疗法：回顾与展望。
Biologia (Bratisl). 2023;78(2):291-305. doi: 10.1007/s11756-022-01207-3. Epub 2022 Sep 20.
9
Antibiofilm Activity of Omega-3 Fatty Acids and Its Influence on the Expression of Biofilm Formation Genes on .ω-3脂肪酸的抗生物膜活性及其对……生物膜形成基因表达的影响
Antibiotics (Basel). 2022 Jul 11;11(7):932. doi: 10.3390/antibiotics11070932.
10
Algal Phlorotannins as Novel Antibacterial Agents with Reference to the Antioxidant Modulation: Current Advances and Future Directions.藻多酚类作为新型抗菌剂及其对抗氧化调节的作用：当前进展与未来方向。
Mar Drugs. 2022 Jun 18;20(6):403. doi: 10.3390/md20060403.